| Application no. and date | 08158950.9 (espacenet) (Federated) (European Patent Register), 20041026 | | Patent/reg. no. and date | DK/EP 1992357, 20091223 | | Publication date | 20081119 | | Priority no. and date | US 515362 P, 20031029, US 556150 P, 20040324, US 574957 P, 20040526 | | EP pub. no. and date |
EP 1992357 20081119 | | Effective date | | | Applicant/owner | ALLERGAN, INC., 2525 Dupont Drive
Irvine,
California 92612, US | | Applicant ref. no. | 137543 | | Inventor | Blumenfeld, Andrew M., 5032 Wellworth Point
San Diego, CA 92130, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 39/08 (2006.01) , A61P 25/00 (2006.01) , A61P 25/08 (2006.01) , A61P 25/18 (2006.01) , A61P 25/28 (2006.01) | | Title | Botulinumtoxinbehandlinger af neurologiske og neuropsykiatriske lidelser | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
